Evaluation of the Effectiveness of Bone-anchored Hearing Aids (Baha)

Sponsor
University Hospital, Ghent (Other)
Overall Status
Unknown status
CT.gov ID
NCT01264510
Collaborator
(none)
150
1
1
65
2.3

Study Details

Study Description

Brief Summary

A bone-anchored hearing aid (Baha) consists of a titanium implant located at the mastoid, and a sound processor connected with the implant. The sound processor delivers bone conducted stimuli to the cochlea, bypassing the outer and middle ear.

Some patients who are unable to wear or do not benefit from a conventional air-conduction hearing aid, are candidate for a Baha. Typically, these patients suffer from a conductive or a mixed hearing loss. Recently however, Baha's are also being recommended in patients with unilateral deafness. Sound coming from the deaf side is captured and transmitted through bone conduction to the normal inner ear. The overall benefit of a Baha is more difficult to assess in those patients.

Therefore, the goal of the current study is to examine the benefit of a Baha in patients with different audiological profiles (unilateral or bilateral conductive or mixed hearing loss, and unilateral deafness). Special attention will be given to predictive determinants of the benefit with a Baha, and to the improvement of pre-operative criteria and counseling of patients.

Condition or Disease Intervention/Treatment Phase
  • Other: audiological test battery
Phase 4

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Evaluation of the Effectiveness of Bone-anchored Hearing Aids (Baha) in Patients With Conductive or Mixed Hearing Loss, or Unilateral Deafness
Study Start Date :
Mar 1, 2010
Anticipated Primary Completion Date :
Aug 1, 2015
Anticipated Study Completion Date :
Aug 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Other: patients implanted with a Bone-anchored hearing aid(Baha)

Other: audiological test battery
routine audiological measurements.

Outcome Measures

Primary Outcome Measures

  1. benefit of a Bone-anchored hearing aid (Baha) in patients with different audiological profiles [after 3 months up to 10 years]

    Patients who are already implanted with a Baha at the University Hospital of Ghent will be re-evaluated once using an audiological test battery. This evaluation will take place at least 3 months after implantation for the recently implanted subjects. For the subjects who are implanted in the past, this evaluation will take place maximum 10 years after implantation. The audiological test battery includes measurements of hearing thresholds, speech understanding in quiet and noise, and auditory orientation tests.

Secondary Outcome Measures

  1. evaluation of subjective benefit of the Baha [after 3 months]

    The subjective benefit of the Baha in different situations will be evaluated by means of questionnaires. No measures regarding safety, tolerability or pain will be evaluated because these measures are already verified for the Baha. The outcome measures are strictly related to audiological factors (e.g. the difference in hearing thresholds/ speech understanding/ orientation with and without Baha). The test duration is estimated at 2 hours.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients (males and females) already implanted with a bone-anchored hearing aid (Baha) are included in the study.

  • Only patients above 18 years will be included.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital Ghent Ghent Belgium

Sponsors and Collaborators

  • University Hospital, Ghent

Investigators

  • Principal Investigator: Ingeborg Dhooge, MD, PhD, University Hospital, Ghent

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT01264510
Other Study ID Numbers:
  • 2010/074
First Posted:
Dec 21, 2010
Last Update Posted:
Dec 5, 2014
Last Verified:
Dec 1, 2014

Study Results

No Results Posted as of Dec 5, 2014